Phase I Study of Marizomib + Panobinostat for Children With DIPG
Status:
Active, not recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This research study is evaluating the safety, tolerability and preliminary efficacy of the
drugs marizomib and panobinostat in pediatric patients with diffuse intrinsic pontine glioma
(DIPG).
The names of the study drugs involved in this study are:
- Marizomib
- Panobinostat